Skip to main content
. 2014 Jul 28;26(3):735–745. doi: 10.1681/ASN.2014030228

Figure 2.

Figure 2.

Survival curves at 120 months in patients positive and negative for IgA aB2GPI antibodies. (A) Graft survival during the first 6 months was significantly lower in patients positive for IgA aB2GPI antibodies (group 1) than patients negative for IgA aB2GPI antibodies (group 2). (B) Graft survival from the seventh month to the end of follow-up (not DCGS). No significant differences between groups for graft survival were observed.